IRIS
PICARDI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.909
EU - Europa 3.187
AS - Asia 3.031
SA - Sud America 459
Continente sconosciuto - Info sul continente non disponibili 275
AF - Africa 47
OC - Oceania 5
Totale 35.913
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.684
SG - Singapore 1.385
DE - Germania 867
CN - Cina 669
RU - Federazione Russa 405
UA - Ucraina 381
IT - Italia 380
BR - Brasile 366
IE - Irlanda 293
GB - Regno Unito 270
VN - Vietnam 251
HK - Hong Kong 240
FR - Francia 163
CA - Canada 159
FI - Finlandia 125
SE - Svezia 121
BD - Bangladesh 110
KR - Corea 100
JP - Giappone 76
PL - Polonia 66
IN - India 46
AR - Argentina 40
IQ - Iraq 24
NL - Olanda 24
MX - Messico 23
UZ - Uzbekistan 22
ZA - Sudafrica 20
CR - Costa Rica 18
ES - Italia 18
AT - Austria 14
BE - Belgio 13
EC - Ecuador 13
ID - Indonesia 12
CL - Cile 11
PK - Pakistan 11
CZ - Repubblica Ceca 10
JM - Giamaica 9
AE - Emirati Arabi Uniti 8
MY - Malesia 8
PH - Filippine 8
SA - Arabia Saudita 8
TR - Turchia 8
CO - Colombia 7
IR - Iran 7
KG - Kirghizistan 6
PY - Paraguay 6
AU - Australia 5
CH - Svizzera 5
EU - Europa 5
IL - Israele 5
PE - Perù 5
UY - Uruguay 5
BG - Bulgaria 4
DK - Danimarca 4
EG - Egitto 4
GR - Grecia 4
HN - Honduras 4
LT - Lituania 4
NP - Nepal 4
RO - Romania 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DZ - Algeria 3
ET - Etiopia 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
TN - Tunisia 3
TW - Taiwan 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
GT - Guatemala 2
HU - Ungheria 2
NI - Nicaragua 2
OM - Oman 2
PT - Portogallo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AI - Anguilla 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
DM - Dominica 1
EE - Estonia 1
GM - Gambi 1
GY - Guiana 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
PA - Panama 1
Totale 35.638
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.789
Wilmington 7.525
Houston 6.616
Fairfield 814
Ann Arbor 717
Singapore 671
Ashburn 598
Chandler 472
San Jose 357
Seattle 339
Jacksonville 312
Cambridge 275
Dublin 264
Beijing 255
Hong Kong 239
Medford 205
Dearborn 192
Munich 161
New York 160
Rome 136
Council Bluffs 129
Santa Clara 116
Mcallen 112
Montréal 110
Los Angeles 100
Lawrence 98
The Dalles 92
Zhengzhou 86
Dallas 83
Ho Chi Minh City 72
Moscow 66
Lauterbourg 64
Tokyo 61
Helsinki 56
Hanoi 54
Buffalo 45
Kraków 45
San Diego 43
Menlo Park 35
Orem 34
Mülheim 32
São Paulo 31
Milan 30
London 25
Chicago 23
Redondo Beach 23
Frankfurt am Main 20
Boardman 18
Kunming 18
Phoenix 18
Shanghai 18
San José 17
Warsaw 17
Denver 16
Johannesburg 16
Norwalk 16
Falls Church 15
Atlanta 14
Bologna 14
Montreal 14
Nanjing 14
Nürnberg 14
San Mateo 14
University Park 14
Brussels 13
Da Nang 13
Guangzhou 13
Haiphong 13
Nuremberg 13
Rio de Janeiro 13
Toronto 13
Brooklyn 12
Chennai 12
Columbus 12
Hefei 12
Belo Horizonte 11
Saint Petersburg 11
Palo Alto 10
San Francisco 10
Baghdad 9
North Bergen 9
Porto Alegre 9
Seoul 9
Verona 9
Washington 9
Brno 8
Nanchang 8
New Delhi 8
Boston 7
Charlotte 7
Dhaka 7
Hounslow 7
Hải Dương 7
Jakarta 7
Mumbai 7
Redmond 7
Redwood City 7
Stockholm 7
Cleveland 6
Creede 6
Totale 30.390
Salva come PNG Salva come JPEG
Nome #
Awake thoracoscopic biopsy of anterior mediastinal masses 880
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 586
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 552
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 524
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 515
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 504
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 501
Acute foetal distress and umbilical cord blood banking 500
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia 492
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 484
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant 481
Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors 479
Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. 476
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 471
Cord blood transplantation in adults with acute myeloid leukaemia. 469
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 466
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation 459
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 458
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network 453
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 451
Placental/Umbilical cord blood: experience of St. Eugenio Hospital collection center 448
The therapeutic use of cord blood 448
Unrelated Cord Blood transplantaion for children with high risk myelodysplastic syndrome 444
Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures 442
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 441
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 441
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant 439
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 432
Algorithm for donor selection in 2011 427
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 426
Outcomes of allogeneic stem cell transplantation for secondary therapy-related acute myeloid leukaemia 424
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 424
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 423
Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients 423
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 423
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 421
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies 420
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 419
Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress 419
Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation 418
Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma 414
Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission 414
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors 412
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 412
BK virus DNA detection by real-time polymerase chain reaction in clinical specimens 410
Zoledronic acid-associated thrombotic thrombocytopenic purpura [1] 410
Diagnosis of acute foetal distress does not preclude banking of umbilical cord blood units 407
Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia. 407
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 405
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT. 402
Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors 402
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. 399
Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network 399
The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia 396
Platelet gel is highly effective in treating muco-cutaneous lesions related to graft-versus-host disease 386
Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts 382
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 378
Organizzazione e attività delle Banche di sangue placentare 377
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma 375
CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA 373
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 373
Quality controls of cord blood units according to JACIE standards are highly predictive in unrelated cord blood transplant 367
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 366
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 366
Identification of the novel allele, HLA-A*02:653, in an Italian patient 366
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 363
Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. 360
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord and G-CSF stimulated peripheral blood 355
Impact of HLA mismatch direction on outcome after umbilical cord blood transplantation for hematological malignant disorders: a retrospective eurocord-EBMT analysis. 353
Il Trapianto di Cellule Stminali Emopoietiche. 335
Unmanipulated bone marrow transplantation from haplo-identical related donor for patients with high-risk haematological malignancies 328
Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study 324
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey 321
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 297
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 296
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update 285
Gemtuzumab ozogamicin in combination with intensive chemotherapy for relapsed/refractory acute myeloid leukemia 283
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease 263
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 240
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 222
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 198
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies 194
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML 192
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 192
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia 189
Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor 182
Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 179
Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective 177
Is there still a role for autologous stem cell transplantation for the treatment of acute myeloid leukemia? 168
Is outcome of older people with acute myeloid leukemia improving with new therapeutic approaches and stem cell transplantation? 162
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 158
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 157
Allelic HLA matching and pair origin are favorable prognostic factors for unrelated hematopoietic stem cell transplantation in neoplastic hematologic diseases: an Italian analysis by the Gruppo italiano trapianto di cellule staminali e terapie cellulari, Italian bone marrow donor registry, and Associazione Italiana di immunogenetica e biologia dei trapianti 112
Incidence of HLA loss in a global multicentric cohort of post-transplantation relapses: results from the Hlaloss Collaborative Study 107
Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation 68
Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation 67
Permissive HLA-DPB1 mismatch and survival after unrelated donor allogeneic stem cell transplantation for hematological malignancies: a comparative analysis of different immunogenetic models on 422 patients from GITMO and IBMDR 63
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation 62
High resolution donor/recipient HLA matching level in unrelated hematopoietic stem cell transplantation and impact on the transplant outcome: the Italian experience on behalf of GITMO, IBMDR and Aibt 60
Totale 35.913
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.493
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022917 0 120 47 38 23 67 68 55 49 96 71 283
2022/20231.205 147 106 56 158 73 287 95 75 111 6 65 26
2023/2024447 49 10 26 8 51 131 37 11 14 3 1 106
2024/20251.951 81 428 177 131 48 98 174 106 189 228 127 164
2025/20263.552 252 207 429 331 335 127 464 356 424 342 163 122
2026/2027315 156 159 0 0 0 0 0 0 0 0 0 0
Totale 35.913